7-93101374-C-T
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_017654.4(SAMD9):c.4724G>A(p.Gly1575Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00168 in 1,613,358 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1575V) has been classified as Uncertain significance.
Frequency
Consequence
NM_017654.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SAMD9 | NM_017654.4 | c.4724G>A | p.Gly1575Glu | missense_variant | 3/3 | ENST00000379958.3 | |
SAMD9 | NM_001193307.2 | c.4724G>A | p.Gly1575Glu | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SAMD9 | ENST00000379958.3 | c.4724G>A | p.Gly1575Glu | missense_variant | 3/3 | 1 | NM_017654.4 | P1 | |
SAMD9 | ENST00000620985.4 | c.4724G>A | p.Gly1575Glu | missense_variant | 2/2 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00120 AC: 183AN: 152038Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00166 AC: 418AN: 251144Hom.: 0 AF XY: 0.00162 AC XY: 220AN XY: 135746
GnomAD4 exome AF: 0.00173 AC: 2522AN: 1461320Hom.: 3 Cov.: 32 AF XY: 0.00167 AC XY: 1213AN XY: 726972
GnomAD4 genome AF: 0.00120 AC: 183AN: 152038Hom.: 0 Cov.: 32 AF XY: 0.00141 AC XY: 105AN XY: 74268
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 30, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 28545555) - |
Uncertain significance, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 24, 2021 | DNA sequence analysis of the SAMD9 gene demonstrated a sequence change, c.4724G>A, in exon 3 that results in an amino acid change, p.Gly1575Glu. This sequence change does not appear to have been previously described in patients with SAMD9-related disorders. This sequence change has been described in the gnomAD database with a population frequency of 0.83% in the Finnish subpopulation (dbSNP rs148724199). The p.Gly1575Glu change affects a moderately conserved amino acid residue located in a domain of the SAMD9 protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Gly1575Glu substitution. Due to this insufficient evidence and the lack of functional studies, the clinical significance of the p.Gly1575Glu change remains unknown at this time. - |
SAMD9-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 19, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at